New Product Innovations Respond to Patient Needs Across Medical Category

Tilray, Inc. (“Tilray”) (Nasdaq I TSX: TLRY), a global pioneer in medical cannabis research, cultivation, and production, today announced the launch of medical cannabis edibles in THC and CBD-rich varieties of chocolates and soft chew gummies. The new Tilray-branded medical cannabis edibles are now available for patients across Canada and add to the brand’s comprehensive offering of cannabis medicines, including whole flower, oils, vapes, and pre-rolls developed with patient health and wellbeing in mind.

Irwin D. Simon, Tilray’s Chairman and Chief Executive Officer, said, “Whether it’s pain management, anxiety treatment, or everything in between, patients are asking for more choices in the medical cannabis category, and Tilray remains committed to the innovations that improve patient wellbeing. As cannabis regulations evolve around the world, we look forward to offering our global patient community the highest-quality medicines they depend on for health, wellness and wellbeing.”

Tilray’s new medical cannabis edibles include two formulations of 16-gram medical cannabis-infused chocolate bars in THC Milk Chocolate containing 10mg of THC and <1mg of CBD per package and CBD Dark Chocolate containing 1mg of THC and 20mg of CBD per package, as well as two formulations of medical cannabis soft chews available in Watermelon containing 10mg of THC and Pineapple-Mango containing 10mg of THC and 10mg of CBD.

Jim Meiers, President at Tilray Canada, said, “Tilray continues to deliver the benefits of cannabis safely and reliably in unique formats that suit patients’ needs. Our goal is to help provide patients access to the highest-quality medical cannabis products that can improve their quality of life, and also support them with best-in-class service and programs so they make the choices best suited to their needs.”

For more information about Tilray medical cannabis products, visit: www.Tilray.ca

About Tilray Inc.

Tilray, Inc. is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information about Tilray, Inc., visit: www.Tilray.com

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Aphria and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with applicable securities regulatory authorities and available on SEDAR and EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

For media inquiries, please contact: Berrin Noorata news@tilray.com For investor inquiries, please contact: Raphael Gross 203-682-8253 Raphael.Gross@icrinc.com

Tilray (NASDAQ:TLRY)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more Tilray Charts.
Tilray (NASDAQ:TLRY)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more Tilray Charts.